Literature DB >> 22957803

2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.

Myeong Seop Kim1, HyungChul Ryu, Dong Wook Kang, Seong-Hee Cho, Sejin Seo, Young Soo Park, Mi-Yeon Kim, Eun Joo Kwak, Yong Soo Kim, Rahul S Bhondwe, Ho Shin Kim, Seul-gi Park, Karam Son, Sun Choi, Ian A DeAndrea-Lazarus, Larry V Pearce, Peter M Blumberg, Robert Frank, Gregor Bahrenberg, Hannelore Stockhausen, Babette Y Kögel, Klaus Schiene, Thomas Christoph, Jeewoo Lee.   

Abstract

A series of N-(2-amino-6-trifluoromethylpyridin-3-ylmethyl)-2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides were designed combining previously identified pharmacophoric elements and evaluated as hTRPV1 antagonists. The SAR analysis indicated that specific hydrophobic interactions of the 2-amino substituents in the C-region of the ligand were critical for high hTRPV1 binding potency. In particular, compound 49S was an excellent TRPV1 antagonist (K(i(CAP)) = 0.2 nM; IC(50(pH)) = 6.3 nM) and was thus approximately 100- and 20-fold more potent, respectively, than the parent compounds 2 and 3 for capsaicin antagonism. Furthermore, it demonstrated strong analgesic activity in the rat neuropathic model superior to 2 with almost no side effects. Compound 49S antagonized capsaicin induced hypothermia in mice but showed TRPV1-related hyperthermia. The basis for the high potency of 49S compared to 2 is suggested by docking analysis with our hTRPV1 homology model in which the 4-methylpiperidinyl group in the C-region of 49S made additional hydrophobic interactions with the hydrophobic region.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22957803      PMCID: PMC3469757          DOI: 10.1021/jm300780p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

1.  N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.

Authors:  Yong Soo Kim; Min-Jung Kil; Sang-Uk Kang; HyungChul Ryu; Myeong Seop Kim; Yongsung Cho; Rahul S Bhondwe; Shivaji A Thorat; Wei Sun; Keliang Liu; Jin Hee Lee; Sun Choi; Larry V Pearce; Vladimir A Pavlyukovets; Matthew A Morgan; Richard Tran; Jozsef Lazar; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2011-11-22       Impact factor: 3.641

2.  Analgesic potential of TRPV1 antagonists.

Authors:  Philip R Kym; Michael E Kort; Charles W Hutchins
Journal:  Biochem Pharmacol       Date:  2009-03-05       Impact factor: 5.858

Review 3.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

4.  The cloned capsaicin receptor integrates multiple pain-producing stimuli.

Authors:  M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

5.  Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies.

Authors:  Jin Hee Lee; Yoonji Lee; HyungChul Ryu; Dong Wook Kang; Jeewoo Lee; Jozsef Lazar; Larry V Pearce; Vladimir A Pavlyukovets; Peter M Blumberg; Sun Choi
Journal:  J Comput Aided Mol Des       Date:  2011-03-30       Impact factor: 3.686

6.  Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.

Authors:  Elizabeth M Doherty; Christopher Fotsch; Yunxin Bo; Partha P Chakrabarti; Ning Chen; Narender Gavva; Nianhe Han; Michael G Kelly; John Kincaid; Lana Klionsky; Qingyian Liu; Vassil I Ognyanov; Rami Tamir; Xianghong Wang; Jiawang Zhu; Mark H Norman; James J S Treanor
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

7.  2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions.

Authors:  Wei Sun; Keliang Liu; HyungChul Ryu; Dong Wook Kang; Yong Soo Kim; Myeong Seop Kim; Yongsung Cho; Rahul S Bhondwe; Shivaji A Thorat; Ho Shin Kim; Larry V Pearce; Vladimir A Pavlyukovets; Richard Tran; Matthew A Morgan; Jozsef Lazar; Christopher B Ryder; Attila Toth; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2011-12-23       Impact factor: 3.641

8.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

9.  The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

Authors:  Narender R Gavva; Anthony W Bannon; Sekhar Surapaneni; David N Hovland; Sonya G Lehto; Anu Gore; Todd Juan; Hong Deng; Bora Han; Lana Klionsky; Rongzhen Kuang; April Le; Rami Tamir; Jue Wang; Brad Youngblood; Dawn Zhu; Mark H Norman; Ella Magal; James J S Treanor; Jean-Claude Louis
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

10.  Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin.

Authors:  D J de Vries; P M Blumberg
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

View more
  16 in total

1.  Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Jihyae Ann; Aeran Jung; Mi-Yeon Kim; Hyuk-Min Kim; HyungChul Ryu; Sunjoo Kim; Dong Wook Kang; Sunhye Hong; Minghua Cui; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2015-10-09       Impact factor: 3.641

2.  α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists.

Authors:  Phuong-Thao Tran; Ho Shin Kim; Jihyae Ann; Sung-Eun Kim; Changhoon Kim; Mannkyu Hong; Van-Hai Hoang; Van T H Ngo; Sunhye Hong; Minghua Cui; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2015-04-12       Impact factor: 2.823

3.  Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.

Authors:  Zhiwei Feng; Larry V Pearce; Xiaomeng Xu; Xiaole Yang; Peng Yang; Peter M Blumberg; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2015-02-18       Impact factor: 4.956

4.  t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Sunho Lee; Dong Wook Kang; HyungChul Ryu; Changhoon Kim; Jihyae Ann; Hobin Lee; Eunhye Kim; Sunhye Hong; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2017-03-06       Impact factor: 3.641

5.  Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.

Authors:  Hobin Lee; Songyeon Ahn; Jihyae Ann; Heejin Ha; Young Dong Yoo; Young Ho Kim; Ji-Young Hwang; Kwang-Hyun Hur; Choon-Gon Jang; Larry V Pearce; Timothy E Esch; Nancy E Lewin; Peter M Blumberg; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2019-08-21       Impact factor: 6.514

6.  Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Sunho Lee; Changhoon Kim; Jihyae Ann; Shivaji A Thorat; Eunhye Kim; Jongmi Park; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-08-12       Impact factor: 2.823

7.  2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Jihyae Ann; Yooran Ki; Suyoung Yoon; Myeong Seop Kim; Jung-Un Lee; Changhoon Kim; Sunho Lee; Aeran Jung; Jisoo Baek; Sunhye Hong; Sun Choi; Larry V Pearce; Timothy E Esch; Noe A Turcios; Nancy E Lewin; Adebowale E Ogunjirin; Brienna K A Herold; Anna K McCall; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2016-01-28       Impact factor: 3.641

8.  Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.

Authors:  Myeong Seop Kim; Yooran Ki; Song Yeon Ahn; Suyoung Yoon; Sung-Eun Kim; Hyeung-Geun Park; Wei Sun; Karam Son; Minghua Cui; Sun Choi; Larry V Pearce; Timothy E Esch; Ian A Deandrea-Lazarus; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2013-11-06       Impact factor: 2.823

9.  2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region.

Authors:  Shivaji A Thorat; Dong Wook Kang; HyungChul Ryu; Myeong Seop Kim; Ho Shin Kim; Jihyae Ann; Taehwan Ha; Sung-Eun Kim; Karam Son; Sun Choi; Peter M Blumberg; Robert Frank; Gregor Bahrenberg; Klaus Schiene; Thomas Christoph; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2013-04-11       Impact factor: 6.514

10.  2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.

Authors:  HyungChul Ryu; Sejin Seo; Myeong Seop Kim; Mi-Yeon Kim; Ho Shin Kim; Jihyae Ann; Phuong-Thao Tran; Van-Hai Hoang; Jieun Byun; Minghua Cui; Karam Son; Pankaz Kumar Sharma; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Babette-Yvonne Koegel; Thomas Christoph; Sven Frormann; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2014-06-02       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.